The Exchange has sought clarification from Sharon Bio-Medicine on September 20, 2016, with reference to news flashed on ET NOW dated September 20, 2016 stating ‘USFDA approves Sharon Bios Taloja API plant’.
The above information is a part of company’s filings submitted to BSE.